Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NABsys-Affiliated Scientists Receive Two of the Eight ‘Revolutionary Genome Sequencing Technologies – The $1,000 Genome’ Awards from the National Huma

Abstract:
NABsys is Only For-Profit Entity to Receive an Award

NABsys-Affiliated Scientists Receive Two of the Eight ‘Revolutionary Genome Sequencing Technologies – The $1,000 Genome’ Awards from the National Huma

PROVIDENCE, RI | Posted on August 2nd, 2007

NABsys, Inc. announced today that two NABsys-affiliated scientists, Dr. John Oliver, Vice President of Research and Development, and Dr. Xinsheng Sean Ling, NABsys founder and principal academic collaborator and Associate Professor of Physics at Brown University, have received two of the eight "Revolutionary Genome Sequencing Technologies - The $1,000 Genome" awards from the National Human Genome Research Institute (NHGRI), an institute of the National Institutes of Health (NIH). NABsys was the only company, rather than academic lab, to receive an award. The funds will support the development of NABsys' proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform which the company expects will decrease the cost of whole-genome sequencing to well under $1,000 per person/patient, allowing for the widespread implementation of personalized medicine.

"We are pleased that the NHGRI recognizes the value of the NABsys sequencing platform," said Dr. Barrett Bready, NABsys President and CEO. "The fact that two of the eight scientists to receive ‘$1,000 genome' money were part of the NABsys team is a great validation of our proprietary approach. Additionally, the fact that NABsys is the only company to receive an award this year is further validation of the potential of the platform."

The genetic basis of the most deadly diseases, including heart disease, cancer, and stroke, is not well understood. Understanding the underlying genetics associated with these diseases would lead to a more rational approach to drug design and would allow for personalized, predictive, and preventive medicine. The primary impediment to gaining this understanding and to the implementation of personalized medicine has been the high cost of DNA sequencing.

Dr. Oliver's grant is a two-year $500,000 award made to NABsys. Dr. Ling's grant is a three-year $820,000 award made to Brown University. NABsys has an exclusive licensing agreement with Brown.

"The NABsys sequencing platform, Hybridization-Assisted Nanopore Sequencing combines nanopore sequencing and sequencing by hybridization to create a platform that is much more powerful than either alone," said Dr. John Oliver, Vice President of Research and Development. "These awards will help accelerate the work of our interdisciplinary team as they refine the physics, biochemistry, and computer science associated with HANS."

####

About NABsys, Inc.
NABsys is a nanobiotechnology company developing a next-generation DNA sequencing platform that the company believes will allow an entire human genome to be sequenced for less than $1,000, ultimately enabling personalized medicine. The company’s platform, Hybridization-Assisted Nanopore Sequencing (HANS) uses nanotechnology-based detectors known as nanopores and is being developed in collaboration with researchers at Brown University. The company was founded in 2004 and is located in Providence, RI. To learn more about NABsys, please visit http://www.nabsys.com .

For more information, please click here

Contacts:
Cutler & Company
Andy Cutler
401-743-7842

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Light pulses control graphene's electrical behavior: Finding could allow ultrafast switching of conduction, and possibly lead to new broadband light sensors August 1st, 2014

President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014

Stanford researchers seek 'Holy Grail' in battery design: Pure lithium anode closer to reality with development of protective layer of interconnected carbon domes August 1st, 2014

Air Force’s 30-year plan seeks 'strategic agility' August 1st, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014

New imaging agent provides better picture of the gut July 25th, 2014

Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

Nanobiotechnology

Taking the guesswork out of cancer therapy: New molecular test kit predicts patient’s survival and drug response August 1st, 2014

Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014

Seeing is bead-lieving: Rice University scientists create model 'bead-spring' chains with tunable properties July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE